SUVRETTA CAPITAL MANAGEMENT, LLC - Q1 2017 holdings

$3.21 Billion is the total value of SUVRETTA CAPITAL MANAGEMENT, LLC's 39 reported holdings in Q1 2017. The portfolio turnover from Q4 2016 to Q1 2017 was - .

 Value Shares↓ Weighting
No holdings reported for quarter Q1 2017
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2017-05-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ADOBE SYSTEMS INCORPORATED33Q4 202113.2%
CONSTELLATION BRANDS INC20Q4 201810.9%
AMAZON COM INC20Q3 20238.0%
UNITEDHEALTH GROUP INC20Q3 20235.7%
IQVIA HLDGS INC19Q3 20237.3%
RESTAURANT BRANDS INTL INC18Q3 20198.9%
UNION PAC CORP17Q2 20235.1%
META PLATFORMS INC16Q3 202310.9%
COPART INC15Q4 20212.3%
SUTRO BIOPHARMA INC15Q3 20231.9%

View SUVRETTA CAPITAL MANAGEMENT, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
SUVRETTA CAPITAL MANAGEMENT, LLC Q1 2017 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Zura Bio LtdJune 15, 20232,850,0006.6%
InflaRx N.V.April 24, 20235,733,91010.3%
Benitec Biopharma Inc.April 18, 20233,020,21410.0%
Aeglea BioTherapeutics, Inc.February 13, 20236,376,37310.0%
Bolt Biotherapeutics, Inc.Sold outFebruary 13, 202300.0%
Cano Health, Inc.Sold outFebruary 13, 202300.0%
CHIMERIX INCSold outFebruary 13, 202300.0%
Disc Medicine, Inc.Sold outFebruary 13, 202300.0%
OTONOMY, INC.Sold outFebruary 13, 202300.0%
Sio Gene Therapies Inc.Sold outFebruary 13, 202300.0%

View SUVRETTA CAPITAL MANAGEMENT, LLC's complete significant-ownership history.

Latest filings
TypeFiled
32024-05-02
SC 13D2024-04-29
SC 13G2024-04-15
13F-HR2024-02-14
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13

View SUVRETTA CAPITAL MANAGEMENT, LLC's complete filings history.

Compare quarters

Export SUVRETTA CAPITAL MANAGEMENT, LLC's holdings